Affiliation:
1. Department of Pharmacology The University of Michigan Medical School Ann Arbor Michigan
Abstract
A commentary on current national and international regulation of benzodiazepine‐like drugs is presented. The policies and decision making associated with these regulations also are discussed, both in terms of historical mistakes and current problems. Finally, a proposal is made to improve the methods by which regulations are put into effect.
Subject
Pharmacology (medical),Pharmacology